Jay Olson from Oppenheimer sets a price target of $30 for Immuneering Corporation (NASDAQ:IMRX), indicating a significant potential upside.Immuneering announces an underwritten public offering of 18.96 million shares, aiming to raise approximately$175 million.The company's stock shows volatility, with a current decrease of 13.33%, amidst its efforts to strengthen its financial position through strategic financial activities.On September 25, 2025, Jay Olson from Oppenheimer set a price target of $30 for Imm ...